glutathione in ovarian cancer a double-edged sword Frontiers Redox Biomarkers and Matrix Remodeling
Description
The 2023 Frias Lancet Phase 2 trial documented glycemic outcomes for the combination in type 2 diabetes (PMID 37364590)
Densitometry was performed using Quantity One software
The ratio of GSH to GSSG determines cell redox status
Supplementary Figures S2a and b)
